Trends & Business

ADM has announced that its spore-forming probiotic called DE111 has been approved by China’s National Health Commission.

The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.

Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.

Nutritional Outlook talks to Waleria Health's founder and CEO Komal Baldwa about recent research on its shatavari root extract and the menopause support market.

At-home testing and wearable tech will put supplements to the test as consumers measure and track their cardiovascular, liver, and blood sugar health.

The first set of guidelines are for the formulation, labeling, and packaging of melatonin-containing supplements, and the second is relates to the labeling of gummy dietary supplements.

What goes into creating successful functional beverages?

CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.

Nutritional Outlook sits down with Helaina's COO, Paola Delgado, to talk about the lactoferrin market.

The immune health category remains relevant and thriving.

Emerging innovations in tablet tech.

Consumers are seeking benefits beyond energy such as focus and stress relief.

As consumers embrace alcohol-free lifestyles, classic cocktail flavors may be a great way to delivery functional ingredients in beverage and gummy dosage formats.

The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”

Fenuflakes is a formulation that featured debittered, defatted flakes of fenugreek seeds, rich in fiber and high in protein as well as ultra-low in fat and carbohydrates.

The company claims that it can help brands achieve sodium reductions of more than 60% in some applications.

BGG has established new headquarters in Basel, Switzerland, managed by newly appointed CEO Jürgen Nelis.

The brand refresh is centered on two themes: “power your performance,” and “maximize your health span.”

GC Rieber VivoMega has announced that its three omega-3 facilities are running on 100% renewable energy after having implemented an electric steam boiler to power its marine and microalgae omega-3 operations.

The new ingredient, called Zynamite S, was developed by PLT’s innovation partner Nektium Pharma.

The gummies, called Youth, Balance, and Sutra, will be sold exclusively at The Vitamin Shoppe and Super Supplements stores and on vitaminshoppe.com.

Both NPA and CRN have filed lawsuits against the state to block to law, which is supposed to go into effect on April 22, 2024.

FDA has published a draft guidance on new dietary ingredient notification master files.

The Alkemist Assured seal adds a layer of trust and confidence as the lab’s verification process involves the comprehensive testing of the product’s potency, identity, and purity.

At this year’s SupplySide East, taking place on April 16 and 17 in Secaucus, NJ, Women in Nutraceuticals (WIN) will be hosting a networking event and partnering on an education session titled “Substantiating Products for Women – Building Trust Through Science.”

Innovations in dosage form solutions are allowing for more convenient and complex formulations that make supplementation easier for the end consumer.

In the wake of the passing of founder Muhammed Majeed, PhD, Sami-Sabinsa Group has announced that Majeed’s daughter Anju Majeed, PhD, will be assuming the role of Sami-Sabinsa Group’s executive chairperson, while Majeed’s son Shaheen Majeed will be the company’s global managing director and CEO.

Sirio Pharma is delivering immune supporting postbiotics in an approachable gummy format while Kerry is offering multiple benefits via its Plenibiotics postbiotic ingredient.